Let’s face it. The drug industry isn’t focused on improving health. It’s number one goal is to improve sales.
That’s not a conspiracy theory. It’s just reality. And if you have diabetes, it’s a good idea to keep that in mind since the industry tends to see you as a cash cow.
That’s especially true right now as the conventional medical establishment launches a big push to get people off of metformin and onto a new class of medication called SGLT-2 inhibitors.
That push has nothing to do with your health when you get right down to it. Instead, the real reason is that the diabetes drug metformin is now a cheap generic. That means the bottom has dropped out of the drug’s profit potential.
Meanwhile, the SGLT-2 inhibitors are part of an exploding multibillion-dollar diabetes market. And the industry has already said they hope to increase that by billions more.
The establishment is clearly ready to help with that goal. Because they’re out with a new report practically BEGGING people to switch from metformin to SGLT-2 inhibitors.
But as you’ll see in a moment, that swap could come with a terrible toll.
Metformin holds up against newer drugs
A new study claims that SGLT-2 inhibitors are better than metformin for blood sugar control in diabetes. Except that’s NOT quite what the study found.
In fact, by nearly every measure the plain old, super-cheap, and easy-to-find metformin more than held its own in that head-to-head comparison.
The two diabetes drugs were roughly equal in reducing most risk categories, including heart attack, stroke, and death. The only sizable difference was in heart failure risk.
According to the researchers, SGLT-2 inhibitors cut the odds of hospitalization for the condition by about 20 percent.
That’s nothing to sneeze at, of course. But given that metformin matched these newer diabetes drugs in nearly every other way, it’s not exactly groundbreaking either. And that’s especially true when you factor further research on these meds into the picture.
One major analysis a few years back found metformin was just as effective as a first-line diabetes treatment as nearly ALL of the newer and more expensive drugs, including SGLT-2 inhibitors.
And then there are the risks and side effects. They’re always important to consider when choosing to take a drug. But in this case, factoring them in is a must. And you’ll see why in just a moment.
A better way to beat diabetes
With everything else being roughly equal, I wouldn’t blame you for thinking it may be time to give SGLT-2 inhibitors a shot. But don’t sign up for a trial prescription yet.
Like any drug, metformin can come with side effects. Some of the more common ones include gas, bloating, cramps, and stomach pain. But SGLT-2 inhibitors, on the other hand, come with a FAR more alarming side effect.
These newer diabetes drugs have an elevated risk for nasty below-the-belt infections. One of the worst is a terrifying infection called Fournier gangrene. This flesh-eating infection can target the scrotum, penis, and perineum area.
The new study confirms that SGLT-2 inhibitors can DOUBLE your risk of these genital infections compared to metformin. Plus, these same diabetes drugs have been linked to thinning bones, amputations, and more.
If you’re on metformin and it’s working out well for you, I’d suggest you talk with your doctor about sticking with it if a med is still essential.
But the truth is you may not need the metformin either. Because other solutions could help you reign in blood sugar quickly, safely, and effectively. And one of the best, by far, is to switch to a low-carb diet.
This move alone could give you all the blood sugar control you need. But if you’re looking for a little extra help with your diabetes, supplements such as berberine are an excellent option.
[GA_rectangle]
This potent compound from the barberry bush is a natural at reigning in rising sugars. But pair it with THESE other two glucose wranglers, and you have a real diabetes-fighting dream team on your hands.
Of course, don’t quit any meds on your own. Work closely with your doctor to make the switch instead.
Latest posts by Alice Jacob (see all)
- Common “fat” could cut Alzheimer’s risk by HALF - June 25, 2022
- Men THIS threat is BIGGER than prostate cancer - June 24, 2022
- THIS could be Parkinson’s EARLIEST warning sign - June 24, 2022
